Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
placebo + prednisone
- Development stage
- Unknown
- Lead developer
- Amgen
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This combination involves **prednisone**, a corticosteroid used to treat various inflammatory and autoimmune conditions by reducing inflammation and suppressing the immune system, and **placebo**, an inactive substance used as a control in clinical trials. Prednisone is commonly used for conditions like asthma, arthritis, lupus, and severe allergic reactions. The combination is likely used in clinical trials to compare the effects of prednisone against a placebo.
- Other names
- placebo-Assistance Publique - Hôpitaux de Paris-interstitial lung disease-systemic sclerosisPlacebo + Prednisone
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on placebo + prednisone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on placebo + prednisone.